Genvax Technologies

Develops mRNA nanoparticle vaccines for animals

Molecular Biology Intern

Translational Research & Bench BiologyConfirmed live in the last 24 hours

Internship · Summer 2027Ames, IA, USA$16 - $17 /hr

About the Job

Requirements

Pursuit of an associate’s or bachelor’s degree in Molecular Biology, Microbiology, Biochemistry, Genetics, or a related field.
Ability to learn and follow detailed protocols.
Ability to learn good documentation practices.
Previous hands-on laboratory experience is a plus.
Strong attention to detail.
Demonstrated ability to learn and apply new skillsets quickly.
Experience managing independent projects.
Basic computer skills are required.

Responsibilities

Train on and follow existing standard operating procedures, protocols, processes, procedures, and systems to independently conduct experiments.
Work alongside Genvax scientists, learning how the laboratory operates and assisting with vaccine development projects.
Deliver an independent project and present results to the Genvax team.
Maintain detailed experimental records, reports, and inventories in electronic lab notebooks.
Contribute to continuous improvement across tools and processes for internal users.
Perform other duties as assigned in a dynamic startup setting.

Desired Qualifications

Preference will be given to students attending an Iowa college or university, or students who graduated from an Iowa high school and attend a college or university outside of Iowa.
Preference will be given to students within 1–2 years of graduation.

Molecular Biology Intern

Genvax Technologies · Ames, United States · Full-time · Posted 2026-10-06

Salary: USD 16–17

Workplace: on_site

Description

Overview:

Genvax Technologies is a startup animal health company focused on developing self-amplifying mRNA nanoparticle vaccines. Genvax Technologies seeks a Summer 2027 Molecular Biology Intern at our Ames, IA location. Your project will include assisting in the development and validation of vaccine technologies to improve animal health. You will work closely with a mentor to develop and execute an independent project. This is a unique opportunity to work in the early stages of a startup company. This is a paid internship that runs from May 25th to August 14th (dates flexible).

Essential Job Functions:

Train on and follow existing SOPs/protocols, processes, procedures, and systems to independently conduct experiments
Spend time working alongside Genvax scientists learning how the laboratory operates and assisting with vaccine development projects
Deliver an independent project and present results to the Genvax team
Maintain detailed experimental records, reports, and inventories in electronic lab notebooks
Contribute to continuous improvement across tools and processes for internal users
Perform other duties as assigned in a dynamic startup setting

Requirements

Pursuit of an associate’s or bachelor’s degree in Molecular Biology, Microbiology, Biochemistry, Genetics, or related field
Preference will be given to students attending an Iowa college or university, or students that have graduated from an Iowa high school and attend a college or university outside of Iowa
Preference will be given to students within 1-2 years of graduation
Ability to learn and follow protocols that have a high degree of detail
Ability to learn good documentation practices
Previous hands-on laboratory experience is a plus
Strong attention to detail
Demonstrated ability to learn and apply new skillsets quickly
Experience managing independent projects
Basic computer skills required

Benefits

Paid Internship. $16-$17 per hour, with 30-40 hours per week.
We are willing to work with your department if you need this internship to count for credit, depending on the requirements

Apply

Apply at Genvax Technologies

About the Company

Genvax Technologies

Develops mRNA nanoparticle vaccines for animals

Genvax Technologies develops mRNA nanoparticle vaccines for animals to prevent and treat veterinary diseases, serving livestock producers, clinics, and animal health organizations. Its vaccines use an mRNA platform packaged in nanoparticles to trigger an immune response, with products advanced through R&D and then sold commercially. The company differentiates itself with a founder-led team tied to a proven track record in animal vaccines and a rapid-response approach to new animal health challenges. Its goal is to improve global animal health by quickly bringing effective animal vaccines to market.

Company size: 1-10
Company stage: Early VC
Total funding: $10.1M
Headquarters: Ames, IA
Founded: 2021

Recently Posted Jobs

Explore more opportunities at Genvax Technologies

See more jobs